The success of a new drug depends not only on scientific innovation and regulatory approval but … How Sales Feedback Can Improve Drug Development DecisionsRead more
Drug development
How Better Trial Recruitment Shortens Time to Market
Efficient patient recruitment is one of the most critical factors in accelerating clinical trials and bringing … How Better Trial Recruitment Shortens Time to MarketRead more
Why Many Drugs Fail Due to Poor Market Fit in the U.S. Pharmaceutical Market
The development of a new pharmaceutical drug represents one of the most resource-intensive processes in modern … Why Many Drugs Fail Due to Poor Market Fit in the U.S. Pharmaceutical MarketRead more
Why Clinical Trial Complexity Keeps Increasing
Clinical trials have always been central to pharmaceutical innovation. They provide the scientific evidence regulators require … Why Clinical Trial Complexity Keeps IncreasingRead more
How Better Data Sharing Speeds Drug Development
The process of developing a new drug is long, expensive, and scientifically complex. On average, bringing … How Better Data Sharing Speeds Drug DevelopmentRead more
How Clinical Trial Delays Affect Investor Confidence
Clinical trials represent the most critical and expensive stage in pharmaceutical development. Before a new therapy … How Clinical Trial Delays Affect Investor ConfidenceRead more
The Hidden Costs of Failed Clinical Trials
Clinical trial failure is often framed as a scientific setback – a missed endpoint, an unexpected … The Hidden Costs of Failed Clinical TrialsRead more
Why Drugs Fail After Phase I in the U.S. Market
In the United States, roughly 12 percent of drugs that enter clinical testing ultimately receive approval … Why Drugs Fail After Phase I in the U.S. MarketRead more
How Poor Communication Between Teams Slows Drug Development
Drug development is often framed as a scientific challenge. Breakthroughs hinge on molecular discovery, biomarker validation, … How Poor Communication Between Teams Slows Drug DevelopmentRead more
Why Regulatory Delays Are Only Part of the U.S. Clinical Trial Problem
When a development program misses projected timelines, the explanation often centers on regulatory review. FDA feedback … Why Regulatory Delays Are Only Part of the U.S. Clinical Trial ProblemRead more